# INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/intellance-2-eortc-1410-randomized-phase-ii-study-of-depatux-m-alone-and-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Martin J. van den Bent,Marica Eoli,Juan Manuel Sepúlveda-Sánchez,Marion Smits,Annemiek Walenkamp,Jean-Sebastian Frenel,Enrico Franceschi,Paul Clement,Olivier Chinot,Filip De Vos,Nicolas Whenham,Paul Sanghera,Michael Weller,H J Dubbink,Pim J. French,Jim Looman,Jyotirmoy Dey,Scott Krause,Pete Ansell,Sarah Nuyens,Maarten Spruyt,Joana Brilhante,Corneel Coens,Thierry Gorlia,Vassilis Golfinopoulos |
| Citations | 192 |
| DOI | 10.1093/neuonc/noz222 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/neuro-oncology/article-pdf/22/5/684/33453984/noz222.pdf |
| OpenAlex ID | https://openalex.org/W2990424668 |
| PMID | 31747009 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Scott Krause](https://scholariq.org/researchers/scott-krause/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Ocular Oncology and Treatments](https://scholariq.org/topics/ocular-oncology-and-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.